LLY
Eli Lilly and Company
Eli Lilly and Company historical holders
total: 12
Viking Global Investors Eli Lilly and Company transactions over time
- Total transactions:
- 13
- New positions:
- 4
- Sold out:
- 4
- Added:
- 2
- Reduced:
- 3
- Held since:
- 2025 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2025 Q3
Ole Andreas Halvorsen has been an institutional investor in Eli Lilly and Company (LLY) since 2015 Q1. According to 2026 Q1 report, Ole Andreas Halvorsen doesn't hold any shares. The fund/company first acquired LLY in 2015 Q1, initially purchasing about 1.40M shares. Ole Andreas Halvorsen later completely sold out the position and reinvested in LLY again in 2025 Q2. Since the initial investment, Viking Global Investors has made 12 more transactions in this position.
When did Ole Andreas Halvorsen exit their LLY position?
Ole Andreas Halvorsen no longer holds Eli Lilly and Company (LLY). They sold off their entire position in 2025 Q3, closing out an investment that began in 2015 Q1.
When did Ole Andreas Halvorsen first invest in LLY?
Ole Andreas Halvorsen first invested in Eli Lilly and Company (LLY) in 2015 Q1 at the reported quarter-end price of $72.65 per share, acquiring 1,398,711 shares in their initial purchase.
What is Ole Andreas Halvorsen's average cost basis for LLY?
Based on historical transaction data, Ole Andreas Halvorsen's estimated cost basis for Eli Lilly and Company (LLY) is approximately $779.53 per share. This represents their average reported price* across all buy transactions.
Has Ole Andreas Halvorsen reinvested in LLY after selling?
Yes, Ole Andreas Halvorsen has shown renewed interest in Eli Lilly and Company (LLY). After completely selling their position, they reinitiated an investment in 2025 Q2, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $779.53
- Weighted AVG sell price:
- $779.53
LLY transactions history by Viking Global Investors
13 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q3
|
0.00%
|
0
|
$779.53
|
|
-100% (-416,918)
|
-0.94%
|
|
2025 Q2
|
0.94%
|
416,918
|
$779.53
|
$325,000,089
|
new
|
+0.94%
|
|
2024 Q4
|
0.00%
|
0
|
$885.94
|
|
-100% (-152,038)
|
-0.49%
|
|
2024 Q3
|
0.49%
|
152,038
|
$885.94
|
$134,696,546
|
+5.45% (+7,863)
|
+0.03%
|
|
2024 Q2
|
0.50%
|
144,175
|
$905.38
|
$130,533,162
|
+7.11% (+9,567)
|
+0.03%
|
|
2024 Q1
|
0.39%
|
134,608
|
$777.96
|
$104,719,640
|
-2.97% (-4,120)
|
-0.01%
|
|
2023 Q4
|
0.30%
|
138,728
|
$582.92
|
$80,867,326
|
new
|
+0.3%
|
|
2016 Q4
|
0.00%
|
$80.26
|
-100% (-6,092,264)
|
|||
|
2016 Q3
|
2.11%
|
$80.26
|
-35.03% (-3,285,131)
|
|||
|
2016 Q2
|
3.14%
|
$78.75
|
-20.29% (-2,386,383)
|
|||
|
2016 Q1
|
3.73%
|
$72.01
|
new
|
|||
|
2015 Q2
|
0.00%
|
$72.65
|
-100% (-1,398,711)
|
|||
|
2015 Q1
|
0.39%
|
$72.65
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.